Chargement en cours...
Hydroxycarbamine: from an Old Drug Used in Malignant Hemopathies to a Current Standard in Sickle Cell Disease
While hydroxycarbamide (hydroxyurea, HU) has less and fewer indications in malignant hemopathies, it represents the only widely used drug which modifies sickle cell disease pathogenesis. Clinical experience with HU for patients with sickle cell disease has been accumulated over the past 25 years in...
Enregistré dans:
| Publié dans: | Mediterr J Hematol Infect Dis |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Università Cattolica del Sacro Cuore
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5333733/ https://ncbi.nlm.nih.gov/pubmed/28293403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2017.015 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|